Vijaya Diagnostic Centre Limited has informed the Exchange about General Updates
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Smallcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre Limited held its Board meeting on May 07, 2026, approving several key items. The Board recommended a final dividend of ₹2 per equity share (200% on face value of ₹1) for FY 2026, subject to shareholder approval at the AGM. An Independent Director, Dr. D Nageshwar Reddy, will not seek re-appointment for a second term due to pre-occupation and other commitments. The company granted 1,79,500 ESOPs to employees at ₹784 per option (20% discount on 3-month average price) under VDCL Employee Stock Option Plan 2018. Additionally, the company approved acquisition of MRI, EEG and NCV services business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore, with operations in Kolkata generating annual turnover of around ₹2.3-2.5 crore.
The dividend recommendation and ESOP grants are positive signals for shareholder returns and employee retention. The acquisition of the diagnostic services business from the subsidiary is a strategic consolidation move that could streamline operations and create growth opportunities. The departure of Dr. Nageshwar Reddy represents a minor governance change with no material concerns noted.